Expertise in

conditions

Athimalaipet V. Ramanan

Charlestown Road,

Manchester, ENG, GB

Clinical Trials:Currently Recruiting for 2 Trials

Expertise in

conditions

Charlestown Road,

Manchester, ENG, GB

Overview

Athimalaipet Ramanan practices in Manchester, United Kingdom. Ramanan is highly rated in 25 conditions, according to our data. Their top areas of expertise are Juvenile Idiopathic Arthritis (JIA), Uveitis, Arthritis, and Chronic Recurrent Multifocal Osteomyelitis.

Their clinical research consists of co-authoring 252 peer reviewed articles and participating in 10 clinical trials. MediFind looks at clinical research from the past 15 years.

Locations

Charlestown Road, Manchester, ENG, United Kingdom

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A Phase 3 Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients From 1 Year to <18 Years of Age With Juvenile Idiopathic Arthritis (JIA)

Enrollment Status: Recruiting

Publish Date: February 10, 2026

Intervention Type: Drug

Study Drug: Baricitnib

Study Phase: Phase 3

Open-Label, Randomized Study With a Tocilizumab Reference Arm to Evaluate Safety, Efficacy and Pharmacokinetics of Baricitinib in Children From 1 to Less Than 18 Years of Age With Systemic Juvenile Idiopathic Arthritis.

Enrollment Status: Recruiting

Publish Date: February 10, 2026

Intervention Type: Drug

Study Drug: Baricitinib

Study Phase: Phase 3

Multicenter, Open-label, Efficacy, Safety, Tolerability, and Pharmacokinetic Study of Subcutaneous Ixekizumab With Adalimumab Reference Arm, in Children With Juvenile Idiopathic Arthritis Subtypes of Enthesitis-related Arthritis (Including Juvenile-Onset Ankylosing Spondylitis) and Juvenile Psoriatic Arthritis

Enrollment Status: Active_not_recruiting

Publish Date: June 05, 2025

Intervention Type: Drug

Study Drugs: Ixekizumab, Adalimumab

Study Phase: Phase 3

Adalimumab in Juvenile Idiopathic Arthritis-associated Uveitis Stopping Trial

Enrollment Status: Completed

Publish Date: May 11, 2025

Intervention Type: Other, Biological

Study Drug: Adalimumab

Study Phase: Phase 4

An Open-label, Active-Controlled, Safety, and Efficacy Study of Oral Baricitinib in Patients From 2 Years to Less Than 18 Years Old With Active Juvenile Idiopathic Arthritis-Associated Uveitis or Chronic Anterior Antinuclear Antibody-Positive Uveitis

Enrollment Status: Active_not_recruiting

Publish Date: April 20, 2025

Intervention Type: Drug

Study Drugs: Baricitinib, Adalimumab

Study Phase: Phase 3

A Randomized, Double-Blind, Placebo-Controlled, Withdrawal, Safety and Efficacy Study of Oral Baricitinib in Patients From 2 Years to Less Than 18 Years Old With Juvenile Idiopathic Arthritis (JIA)

Enrollment Status: Completed

Publish Date: October 07, 2022

Intervention Type: Drug

Study Drug: Baricitnib

Study Phase: Phase 3

View 4 Less Clinical Trials

251 Total Publications

The ADJUST trial and its implications for biologic discontinuation in juvenile idiopathic arthritis-associated uveitis.

Journal: Eye (London, England)

Published: October 26, 2025

View All 251 Publications

Frequently Asked Questions about Athimalaipet V. Ramanan

Is Athimalaipet V. Ramanan a top-rated expert for Juvenile Idiopathic Arthritis (JIA)?

MediFind is an objective health platform that identifies experts based on real-world data. Athimalaipet V. Ramanan is classified as an Elite expert for Juvenile Idiopathic Arthritis (JIA), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Athimalaipet V. Ramanan participate in research or clinical trials?

Yes. Athimalaipet V. Ramanan has published 251 articles and abstracts on conditions like Juvenile Idiopathic Arthritis (JIA). You can view a list of Athimalaipet V. Ramanan's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ramanan's expertise for a condition

ConditionClose